CV19 a help or hindering Tigris?Hey guys and gals. Wondering what everyones opinion is regarding if the situation with CV19 and if it helps boost our chances of an early approval date, or because of the distraction it will delay things? We are still waiting on DIMI which should have been approved weeks ago.... Logic says that with the increase number of patients at the hospitals that are in critical condition and have succumbed to sepsis it should boost and put pressure for early FDA approval... But this be a strange tail this company.... Regards